S&P 500   4,267.52
DOW   33,665.02
QQQ   348.82
Stock market today: Asian shares slip following technology selloff on Wall Street
66,000% upside on tiny biotech? (Ad)
Tesla: How and Why It Gets To $300
Don't Overlook Hidden Gem Kinsale As Rallies To New Highs
"How war impacts the stock market" (Ad)
AI-powered IoT Automation is Driving Samsara To New Highs
What is a Growth Stock Mutual Fund?
"How war impacts the stock market" (Ad)
Persistent inflation, higher interest rates will weigh on global economy, OECD predicts
Sprinklr Gets Targets Raised By Analysts, Here's Why
S&P 500   4,267.52
DOW   33,665.02
QQQ   348.82
Stock market today: Asian shares slip following technology selloff on Wall Street
66,000% upside on tiny biotech? (Ad)
Tesla: How and Why It Gets To $300
Don't Overlook Hidden Gem Kinsale As Rallies To New Highs
"How war impacts the stock market" (Ad)
AI-powered IoT Automation is Driving Samsara To New Highs
What is a Growth Stock Mutual Fund?
"How war impacts the stock market" (Ad)
Persistent inflation, higher interest rates will weigh on global economy, OECD predicts
Sprinklr Gets Targets Raised By Analysts, Here's Why
S&P 500   4,267.52
DOW   33,665.02
QQQ   348.82
Stock market today: Asian shares slip following technology selloff on Wall Street
66,000% upside on tiny biotech? (Ad)
Tesla: How and Why It Gets To $300
Don't Overlook Hidden Gem Kinsale As Rallies To New Highs
"How war impacts the stock market" (Ad)
AI-powered IoT Automation is Driving Samsara To New Highs
What is a Growth Stock Mutual Fund?
"How war impacts the stock market" (Ad)
Persistent inflation, higher interest rates will weigh on global economy, OECD predicts
Sprinklr Gets Targets Raised By Analysts, Here's Why
S&P 500   4,267.52
DOW   33,665.02
QQQ   348.82
Stock market today: Asian shares slip following technology selloff on Wall Street
66,000% upside on tiny biotech? (Ad)
Tesla: How and Why It Gets To $300
Don't Overlook Hidden Gem Kinsale As Rallies To New Highs
"How war impacts the stock market" (Ad)
AI-powered IoT Automation is Driving Samsara To New Highs
What is a Growth Stock Mutual Fund?
"How war impacts the stock market" (Ad)
Persistent inflation, higher interest rates will weigh on global economy, OECD predicts
Sprinklr Gets Targets Raised By Analysts, Here's Why
OTCMKTS:AUGX

Augmedix (AUGX) Stock Forecast, Price & News

$4.17
+0.11 (+2.71%)
(As of 06/7/2023 ET)
Compare
Today's Range
$4.02
$4.17
50-Day Range
$1.65
$4.17
52-Week Range
$1.01
$4.36
Volume
85,481 shs
Average Volume
680,449 shs
Market Capitalization
$169.59 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.50

AUGX stock logo

About Augmedix (OTCMKTS:AUGX) Stock

Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live and Augmedix Notes solutions that provide pre-visit documentation, such as pre-charting and digitization of previous records/patient history; during-visit documentation, including medical notes, care gap reminders, HCC reminders, and after-visit summaries; and post-visit documentation consisting of coding, orders, and referrals. The company enables clinicians to access its applications through mobile devices, such as smartphones or Google Glass. It serves health systems and specialty groups. The company was founded in 2013 and is headquartered in San Francisco, California.

Receive AUGX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Augmedix and its competitors with MarketBeat's FREE daily newsletter.

AUGX Stock News Headlines

"Unknown laser company making HUGE profit from Russia-Ukraine War"
On February 24th, Russia invaded Ukraine. This caused major stock losses and soaring gas prices. But it also created a HUGE opportunity for savvy investors. There's an unknown laser company that's been profiting greatly from this war... ...and from another major conflict happening 3,000 miles away. Learn more here >>>
Analyst Expectations for Augmedix's Future
Benchmark Co. Reaffirms Their Buy Rating on Augmedix (AUGX)
"Unknown laser company making HUGE profit from Russia-Ukraine War"
On February 24th, Russia invaded Ukraine. This caused major stock losses and soaring gas prices. But it also created a HUGE opportunity for savvy investors. There's an unknown laser company that's been profiting greatly from this war... ...and from another major conflict happening 3,000 miles away. Learn more here >>>
Augmedix (AUGX) Gets a Buy from Maxim Group
B.Riley Financial Remains a Buy on Augmedix (AUGX)
Augmedix: Q1 Earnings Insights
Augmedix (OTCMKTS:AUGX) PT Raised to $8.00 at Maxim Group
B. Riley Raises Augmedix (OTCMKTS:AUGX) Price Target to $5.00
Augmedix Blasts Up on New Partnership
See More Headlines

AUGX Price History

AUGX Company Calendar

Last Earnings
3/27/2023
Today
6/07/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Business services, not elsewhere classified
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:AUGX
Fax
N/A
Employees
1,040
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$6.50
High Stock Price Forecast
$8.00
Low Stock Price Forecast
$5.50
Forecasted Upside/Downside
+55.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
$-24,450,000.00
Pretax Margin
-70.10%

Debt

Sales & Book Value

Annual Sales
$30.93 million
Book Value
$0.04 per share

Miscellaneous

Free Float
36,974,000
Market Cap
$169.59 million
Optionable
Not Optionable
Beta
-0.58

Key Executives

  • Mr. Emmanuel Krakaris (Age 63)
    Pres, CEO, Sec. & Director
    Comp: $683.54k
  • Mr. Ian Shakil (Age 37)
    Founder, Chief Strategy Officer & Director
  • Ms. Sandra Breber (Age 64)
    Chief Operating Officer
    Comp: $429.15k
  • Mr. Saurav Chatterjee Ph.D. (Age 50)
    Chief Technology Officer
    Comp: $415.4k
  • Mr. Paul Louis Ginocchio (Age 52)
    Chief Financial Officer
  • Todd Holvick
    Head of Legal & Compliance
  • Lia Wallick
    Head of People
  • Dr. Davin Lundquist M.D.
    Chief Medical Officer
  • Mr. Jonathan Hawkins (Age 52)
    Chief Revenue Officer













AUGX Stock - Frequently Asked Questions

Should I buy or sell Augmedix stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Augmedix in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" AUGX shares.
View AUGX analyst ratings
or view top-rated stocks.

What is Augmedix's stock price forecast for 2023?

3 Wall Street research analysts have issued 1-year price objectives for Augmedix's stock. Their AUGX share price forecasts range from $5.50 to $8.00. On average, they predict the company's share price to reach $6.50 in the next twelve months. This suggests a possible upside of 55.9% from the stock's current price.
View analysts price targets for AUGX
or view top-rated stocks among Wall Street analysts.

How have AUGX shares performed in 2023?

Augmedix's stock was trading at $1.56 at the beginning of the year. Since then, AUGX shares have increased by 167.3% and is now trading at $4.17.
View the best growth stocks for 2023 here
.

How were Augmedix's earnings last quarter?

Augmedix, Inc. (OTCMKTS:AUGX) issued its earnings results on Monday, March, 27th. The company reported ($0.15) EPS for the quarter, beating the consensus estimate of ($0.16) by $0.01. The business earned $8.75 million during the quarter, compared to the consensus estimate of $8.52 million. Augmedix had a negative trailing twelve-month return on equity of 570.66% and a negative net margin of 70.81%.

What guidance has Augmedix issued on next quarter's earnings?

Augmedix issued an update on its FY 2023 earnings guidance on Friday, May, 26th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $42.00M-, compared to the consensus revenue estimate of $41.86 million.

What is Augmedix's stock symbol?

Augmedix trades on the OTCMKTS under the ticker symbol "AUGX."

Who are Augmedix's major shareholders?

Augmedix's stock is owned by a variety of retail and institutional investors. Top institutional investors include Perkins Capital Management Inc. (4.02%), Russell Investments Group Ltd. (3.98%), Cowen Prime Advisors LLC (3.83%), Boston Partners (1.17%), Blair William & Co. IL (0.43%) and Charles Schwab Investment Management Inc. (0.05%). Insiders that own company stock include Mckesson Ventures, Llc and Paul Ginocchio.
View institutional ownership trends
.

How do I buy shares of Augmedix?

Shares of AUGX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Augmedix's stock price today?

One share of AUGX stock can currently be purchased for approximately $4.17.

How much money does Augmedix make?

Augmedix (OTCMKTS:AUGX) has a market capitalization of $169.59 million and generates $30.93 million in revenue each year. The company earns $-24,450,000.00 in net income (profit) each year or ($0.64) on an earnings per share basis.

How many employees does Augmedix have?

The company employs 1,040 workers across the globe.

How can I contact Augmedix?

The official website for the company is www.augmedix.com. The company can be reached via phone at 888-669-4885 or via email at investors@augmedix.com.

This page (OTCMKTS:AUGX) was last updated on 6/8/2023 by MarketBeat.com Staff

My Account -